SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $321,000 | +9.6% | 11,000 | 0.0% | 0.05% | +9.5% |
| Q3 2021 | $293,000 | -13.6% | 11,000 | 0.0% | 0.04% | -6.7% |
| Q2 2021 | $339,000 | +17.7% | 11,000 | 0.0% | 0.04% | +9.8% |
| Q1 2021 | $288,000 | -37.4% | 11,000 | -39.9% | 0.04% | -36.9% |
| Q4 2020 | $460,000 | +20.7% | 18,300 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $381,000 | -12.4% | 18,300 | 0.0% | 0.06% | -7.1% |
| Q2 2020 | $435,000 | +15.1% | 18,300 | -12.9% | 0.07% | +14.8% |
| Q1 2020 | $378,000 | -24.1% | 21,000 | 0.0% | 0.06% | +22.0% |
| Q4 2019 | $498,000 | +105.8% | 21,000 | +138.6% | 0.05% | +100.0% |
| Q3 2019 | $242,000 | – | 8,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |